If Jill quits, I'm out.
For marketing anyways. Numbers are so small that "success" seems to go from 5 to 8 out of 12 patients. Single-arm study has its disadvantages. I guess the three would be happy though. Looks like pr "leak" caused the vol spike yesterday?
Their revenue is moving up. Haven't understood it being so slow to move. Maybe starting now.
About To Double!!